Streetbeat News

Price Targets

PRQR

Raymond James analyst Steven Seedhouse has maintained an 'Outperform' rating on ProQR Therapeutics (NASDAQ:PRQR), but lowered the price target from $5 to $4.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 11:18 am

DDOG

Raymond James analyst Adam Tindle has maintained an 'Outperform' rating on Datadog (NASDAQ:DDOG) and raised the price target from $95 to $115.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 11:07 am

BLUE

Raymond James analyst Dane Leone has maintained an 'Outperform' rating on bluebird bio (NASDAQ:BLUE) and raised the price target from $10 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 11:02 am

EXTR

Needham analyst Alex Henderson has reiterated a 'Buy' rating on Extreme Networks (NASDAQ:EXTR) and maintained a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:54 am

FNA

Needham analyst Mike Matson maintains a 'Buy' rating on Paragon 28 (NYSE:FNA) but has lowered the price target from $24 to $14.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:50 am

SQSP

Piper Sandler analyst Clarke Jeffries maintains an Overweight rating on Squarespace (NYSE:SQSP) and raises the price target from $38 to $40.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:47 am

ADTH

Needham analyst Laura Martin maintains a Buy rating on AdTheorent Holding (NASDAQ:ADTH) but lowers the price target from $3 to $2.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:45 am

MASI

Needham analyst Mike Matson has maintained a 'Buy' rating on Masimo (NASDAQ:MASI) but lowered the price target from $136 to $86.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:44 am

VTEX

Piper Sandler analyst Clarke Jeffries maintains an Overweight rating on Vtex (NYSE:VTEX) and raises the price target from $6 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:42 am

FGBI

Piper Sandler analyst Stephen Scouten has downgraded First Guaranty Bancshares (NASDAQ:FGBI) from Neutral to Underweight and lowered the price target from $12 to $9.5.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:37 am